当前位置: X-MOL首页 › SCI期刊查询及投稿分析系统 › Current Opinion in Biotechnology杂志
Current Opinion in Biotechnology
基本信息
期刊名称 | Current Opinion in Biotechnology CURR OPIN BIOTECH |
---|---|
期刊ISSN | 0958-1669 |
期刊官方网站 | https://www.sciencedirect.com/journal/current-opinion-in-biotechnology |
是否OA | No |
出版商 | Elsevier Ltd |
出版周期 | Bimonthly |
文章处理费 | 登录后查看 |
始发年份 | 1990 |
年文章数 | 131 |
影响因子 | 7.1(2023) scijournal影响因子 greensci影响因子 |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
工程技术1区 | BIOCHEMICAL RESEARCH METHODS 生化研究方法1区 | 是 | 是 |
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物1区 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 16.2 | 1.813 | 1.455 |
Engineering Biomedical Engineering |
18/303 | 94% |
|||
Biochemistry, Genetics and Molecular Biology Biotechnology |
20/311 | 93% |
|||
Chemical Engineering Bioengineering |
16/162 | 90% |
补充信息
自引率 | 2.8% |
---|---|
H-index | 181 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | 登录后查看 |
网友分享审稿时间 | 数据统计中,敬请期待。 |
接受率 | 登录后查看 |
PubMed Central (PMC) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0958-1669%5BISSN%5D |
投稿指南
期刊投稿网址 | https://www.editorialmanager.com/COBIOT |
---|---|
收稿范围 | Review articles in Current Opinion in Biotechnology are by invitation only. Current Opinion in Biotechnology (COBIOT) publishes authoritative, comprehensive, and systematic reviews. COBIOT helps specialists keep up to date with a clear and readable synthesis on current advances biotechnology. Expert authors annotate the most interesting papers from the expanding volume of information published today, saving valuable time and giving the reader insight on areas of importance. Current Opinion in Biotechnology is part of the Current Opinion and Research (CO+RE) suite of journals and is a companion to the new primary research, open access journal, Current Research in Biotechnology (CRBIOT). CO+RE journals leverage the Current Opinion legacy of editorial excellence, high-impact, and global reach to ensure they are a widely read resource that is integral to scientists workflow. Current Opinion in Biotechnology is divided into themed sections, each of which is reviewed once a year. Themes include analytical biotechnology; plant biotechnology; food biotechnology; energy biotechnology; environmental biotechnology; systems biology; nanobiotechnology; tissue, cell and pathway engineering; chemical biotechnology; and pharmaceutical biotechnology. The journal builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. Expertise Expert authors, who are leaders in their field, are invited to write short review articles in which they present recent developments in their subject and provide short annotations to the papers that they think are most relevant. Comprehensiveness There are 27 high-impact Current Opinion review journals in a range of subjects from food science to green and sustainable chemistry. Impact In addition to a vast readership, Current Opinion titles enjoy high citations, Impact Factors, and CiteScores. Selection of topics to be reviewed Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected. Reviews Authors write short review articles in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year. Editorial Overview Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments. Ethics in Publishing: General Statement The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict. For more information, please refer to: https://www.elsevier.com/conflictsofinterest |
收录体裁 | |
投稿指南 | https://www.sciencedirect.com/journal/current-opinion-in-biotechnology/publish/guide-for-authors |
投稿模板 | |
参考文献格式 | |
编辑信息 |
|
我要分享 (欢迎您来完善期刊的资料,分享您的实际投稿经验)